Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Drug Resistant Epilepsy × Cannabidiol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sturge-Weber Syndrome 2 Tuberous Sclerosis 1 Seizures 1 Glioblastoma 1 Drug Resistant Epilepsy 1 Cognitive Dysfunction 1 Chemotherapy-Induced Peripheral Neuropathy 1 Breast Neoplasms 1 Arthralgia 1 Anxiety Disorders 1

Interventions

perampanel 1 Immunoglobulins, Intravenous 1 Cannabidiol 1 Anticonvulsants 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02332655 2022-03-02

Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Phase 1/2 Completed

5 enrolled 8 charts

Drug Resistant Epilepsy, Sturge-Weber Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡